Literature DB >> 6134736

Isolation of Chinese hamster ovary cell mutants requiring the continuous presence of taxol for cell division.

F R Cabral.   

Abstract

Chinese hamster ovary (CHO) cell mutants resistant to the cytotoxic effects of taxol and requiring the drug for normal growth were isolated in a single step. One of these mutant cell lines, Tax-18, fails to divide in the absence of taxol; instead, the cells become larger, rounder, flatter, and multinucleated. Analysis by flow cytometry indicates that during taxol deprivation there is an accumulation of cells in G2 + M phase but that the cells are able to leak through the block in the absence of cell division and further increase their DNA content beyond the tetraploid amount. This interpretation is confirmed by karyotype analysis and by time-lapse studies that show cells rounded for mitosis two to five times longer than in wild-type cultures or in Tax-18 cultures grown in taxol. The cells finally attempt to undergo cytokinesis, fail, and spread out again, but as larger cells than before. Tax-18 has a normal growth rate and morphology when grown in taxol even at concentrations three to five times below the selecting concentration of the drug. The cells, however, have increased sensitivity to microtubule-disrupting drugs such as colcemid, griseofulvin, and D2O. The mutation for taxol auxotrophy behaves recessively in somatic cell hybridization experiments, and the phenotypic reversion rate is approximately 10(-5) in a nonmutagenized population. Both alpha- and beta-tubulin are present in apparently normal amounts and with normal electrophoretic mobilities on two-dimensional gels. The results suggest that Tax-18 lacks a factor necessary for mitosis and that taxol may be able to substitute for this factor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134736      PMCID: PMC2112477          DOI: 10.1083/jcb.97.1.22

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  27 in total

1.  Revertants of a Chinese hamster ovary cell mutant with an altered beta-tubulin: evidence that the altered tubulin confers both colcemid resistance and temperature sensitivity on the cell.

Authors:  F Cabral; I Abraham; M M Gottesman
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

2.  Specific visualization of tubulin-containing structures in tissue culture cells by immunofluorescence. Cytoplasmic microtubules, vinblastine-induced paracrystals, and mitotic figures.

Authors:  K Weber; T Bibring; M Osborn
Journal:  Exp Cell Res       Date:  1975-10-01       Impact factor: 3.905

3.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

4.  Further studies on colchicine-resistant mutants of Chlamydomonas reinhardi.

Authors:  J R Warr; D Gibbons
Journal:  Exp Cell Res       Date:  1974-03-30       Impact factor: 3.905

5.  Microtubule assembly in vitro.

Authors:  G G Borisy; J B Olmsted; J M Marcum; C Allen
Journal:  Fed Proc       Date:  1974-02

6.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine.

Authors:  V Ling; L H Thompson
Journal:  J Cell Physiol       Date:  1974-02       Impact factor: 6.384

7.  Colchicine-resistant mutants of Chlamydomonas reinhardi.

Authors:  M Adams; J R Warr
Journal:  Exp Cell Res       Date:  1972       Impact factor: 3.905

8.  Microtubule formation in vitro in solutions containing low calcium concentrations.

Authors:  R C Weisenberg
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728

9.  Colcemid sensitivity of fission yeast and the isolation of colcemid-resistant mutants.

Authors:  S Lederberg; G Stetten
Journal:  Science       Date:  1970-04-24       Impact factor: 47.728

10.  Action of colchicine and heavy water on the polymerization of microtubules in wheat root meristem.

Authors:  J Burgess; D H Northcote
Journal:  J Cell Sci       Date:  1969-09       Impact factor: 5.285

View more
  17 in total

Review 1.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

2.  Paclitaxel-dependent cell lines reveal a novel drug activity.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

3.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

4.  Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.

Authors:  Hailing Yang; Anutosh Ganguly; Fernando Cabral
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

5.  Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'.

Authors:  Nicolas André; Eddy Pasquier
Journal:  Nat Clin Pract Oncol       Date:  2009-02

Review 6.  New insights into mechanisms of resistance to microtubule inhibitors.

Authors:  Anutosh Ganguly; Fernando Cabral
Journal:  Biochim Biophys Acta       Date:  2011-06-29

7.  Mitotic centromere-associated kinesin (MCAK) mediates paclitaxel resistance.

Authors:  Anutosh Ganguly; Hailing Yang; Mesias Pedroza; Rajat Bhattacharya; Fernando Cabral
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

Review 8.  Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package.

Authors:  Ankur Bahl; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2012-04-28       Impact factor: 1.967

9.  Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

Authors:  L R Kelland; G Abel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance.

Authors:  Shanghua Yin; Changqing Zeng; Malathi Hari; Fernando Cabral
Journal:  Pharm Res       Date:  2012-06-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.